Adenosine triphosphate in cardiac arrhythmias: From therapeutic to diagnostic use

PACE - Pacing and Clinical Electrophysiology

Volumn 25, Issue 1, 2002, Pages 98-102

  Belhassen, Bernard ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE;

DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART PALPITATION; HEART PREEXCITATION; NON INVASIVE MEASUREMENT; QRS COMPLEX; REVIEW; SUPRAVENTRICULAR TACHYCARDIA; WOLFF PARKINSON WHITE SYNDROME;

EID: 0036164440     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2002.00098.x     Document Type: Review

References (41)

1. The physiological activity of adenine compounds with especial reference to their action upon mammalian heart
2. Cardiac nucleotides in hypoxia: Possible role in regulation of coronary blood flow
3. Electrophysiologic effects of adenosine triphosphate and adenosine on the mammalian heart: Clinical and experimental aspects
4. Adenosine triphosphate in paroxysmal tachycardia
5. Adenosine triphosphate in paroxysmal tachycardia
6. L'adenosine triphosphorique dans les tachycardies paroxystiques. Interet diagnostique et therapeutique
7. L'adenosine-5-triphosphorique (Striadyne) dans les arythmies cardiaques
8. Electrophysiologic effects of adenosine-5′-triphosphate on atrioventricular reentrant tachycardia
9. Adenosine: Electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia
10. Comparative clinical and electrophysiologic effects of adenosine triphosphate and verapamil on paroxysmal reciprocating junctional tachycardia
11. Acute management of paroxysmal supraventricular tachycardia: Verapamil, adenosine triphosphate or adenosine?
12. Adenosine for paroxysmal supraventricular tachycardia: Dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials
13. Acute management of paroxysmal atrioventricular junctional reentrant tachycardia: Pharmacologic strategies
14. Cardiac electrophysiology and pharmacology of adenosine: Basic and clinical aspects
15. Adenosine and supraventricular tachycardia
16. Pharmacologic alterations in human type I atrial flutter cycle length and monophasic action potential duration. Evidence for a fully excitable gap in the reentrant circuit
17. Mechanism-specific effects of adenosine on atrial tachycardia
18. Action of adenine derivatives on experimental atrial flutter in the canine heart
19. Electrophysiologic effects of adenosine in patients with supraventricular tachycardia
20. Intravenous adenosine triphosphate during wide QRS tachycardia: Safety, therapeutic efficacy and diagnostic utility
21. Effects of nicorandil, a potassium channel opener, on idiopathic ventricular tachycardia
22. Adenosine-sensitive ventricular tachycardia: Evidence suggesting cyclic AMP-mediated triggered activity
23. Response of non-reentrant catecholamine-mediated ventricular tachycardia to endogenous adenosine and acetylcholine: Evidence for myocardial receptor-mediated effects
24. Sustained left ventricular tachycardia terminated by dipyridamole: Cyclic AMP-mediated triggered activity
25. Adenosine triphosphate sensitive ventricular tachycardia in man
26. Effects of intravenous adenosine on antegrade refractoriness of accessory atrioventricular connections
27. Acceleration of ventricular response to atrial flutter after intravenous adenosine
28. Adenosine in the diagnosis of broad complex tachycardia
29. Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias
30. Les faisceaux de Kent inapparents
31. Use of intravenous adenosine in sinus rhythm as a diagnostic test for latent preexcitation
32. Use of ajmaline in patients with the Wolff-Parkinson-White syndrome to disclose short refractory period of the accessory pathway
33. Unmasking of ventricular preexcitation by adenosine triphosphate: Its usefulness in the assessment of ajmaline test
34. Intravenous adenosine can reveal accessory pathways not revealed by routine electrophysiologic testing
35. Noninvasive diagnosis of dual AV node physiology in patients with AV nodal reentrant tachycardia by administration of adenosine-5′-triphosphate during sinus rhythm
36. Simplified "ATP test" for noninvasive diagnosis of dual AV nodal physiology and assessment of results of slow pathway ablation in patients with AV nodal reentrant tachycardia
37. Noninvasive diagnosis in patients with undocumented tachycardias: Value of the adenosine test to predict AV nodal reentrant tachycardia
38. Atrioventricular node reentry with "smooth" AV node function curves. A different arrhythmia substrate
39. Adenosine-5′-triphosphate test for the noninvasive diagnosis of concealed accessory pathway
40. The adenosine triphosphate test: A bedside diagnostic tool for identifying the mechanism of supraventricular tachycardia in patients with palpitations
41. Dose and rate-dependent effects of adenosine on atrial action potential duration in humans